Shalby's Q4 financials show mixed results, with growth in PBT and PAT but increased interest costs

Shalby, a smallcap healthcare services company, has recently declared its financial results for the quarter ended March 2024. The company has seen a flat financial performance in this quarter, with a score of -3 compared to 1 in the previous quarter.

Despite this, there are some positive aspects to the company's financials. The Profit Before Tax (PBT) has shown a growth of 67.73% year on year, and the Profit After Tax (PAT) has grown by 22.20% year on year. The net sales for the quarter have also shown a positive trend, with a growth of 22.74% year on year and the highest sales in the last five quarters.

However, there are also some areas of concern for Shalby. The interest cost has increased by 78.24% quarter on quarter, indicating increased borrowings. The company's ability to manage interest payments has also deteriorated, with the Operating Profit to Interest ratio being the lowest in the last five quarters.

MarketsMOJO has given a 'Hold' call for Shalby's stock, based on its financial performance in the quarter ended March 2024. Investors should carefully consider these financials before making any investment decisions.